文献速递小儿麻醉心胸血管麻醉

6%羟乙基淀粉(130/0.4)对小儿心脏手术急性肾损伤的影响:前瞻性随机试验

The effect of 6% hydroxyethyl starch (130/0.4) on acute kidney injury in paediatric cardiac surgery: a prospective, randomised trial.
PubMed 文献 · Anaesthesia · 2017-11-17

本研究为前瞻性随机试验,纳入195例小儿心脏手术患者,比较6%羟乙基淀粉130/0.4(最大30 ml.kg-1)与纯晶体液对急性肾损伤的影响。结果显示两组pRIFLE和AKIN标准诊断的急性肾损伤发生率无差异,临床结局无差异,但淀粉组ROTEM提示凝血时间延长、血凝块强度减弱。结论认为术中应用6%羟乙基淀粉130/0.4至30 ml.kg-1与术后急性肾损伤无关。

要点

  • 6%羟乙基淀粉130/0.4(最大30 ml.kg-1)未增加小儿心脏术后急性肾损伤风险。
  • 两组输血、死亡率、主要不良事件、ICU停留和机械通气时间无差异。
  • 淀粉组关胸后ROTEM示凝血时间延长、10分钟血凝块强度和最大血凝块强度减弱。

核心结论

  • 小儿心脏手术术中应用6%羟乙基淀粉130/0.4至30 ml.kg-1未增加术后急性肾损伤。

研究设计与样本

  • 前瞻性随机试验,195例小儿心脏手术患者随机分为羟乙基淀粉组和对照组。

主要发现

  • 急性肾损伤发生率(pRIFLE标准):淀粉组40.8% vs 对照组30.0%,p=0.150。
  • 急性肾损伤发生率(AKIN标准):淀粉组19.6% vs 对照组21.1%,p=0.602。
  • 死亡率、主要不良事件、ICU停留时间、机械通气时间两组无差异。
  • 关胸后ROTEM显示淀粉组凝血时间延长,10分钟血凝块强度和最大血凝块强度减弱。
  • 两组输血无差异,发生急性肾损伤的患者临床病程更差。

临床怎么用

  • 小儿心脏手术中可考虑使用6%羟乙基淀粉130/0.4进行容量复苏,但需限制剂量不超过30 ml.kg-1。
  • 使用羟乙基淀粉时需关注凝血功能变化,ROTEM提示凝血时间延长和血凝块强度减弱。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We have evaluated the effect of a colloid solution on acute kidney injury in paediatric cardiac surgery. A total of 195 patients were ramdomly divided into an hydroxyethyl starch group and a control group. In the starch group, 6% hydroxyethyl starch 130/0.4 (Volulyte® ) was used as the primary fluid for volume resuscitation but was limited to 30 ml.kg-1 . In the control group, only crystalloid fluid was used during the peri-operative period. The incidence of acute kidney injury, peri-operative transfusion, clinical outcomes and laboratory data were compared. The incidence of acute kidney injury determined by Paediatric Risk, Injury, Failure, Loss, End-stage renal disease (pRIFLE) and Acute Kidney Injury Network (AKIN) criteria were no different between the two groups (starch group 40.8% vs. control group 30.0%; p = 0.150 using pRIFLE; 19.6% vs. 21.1% respectively, p = 0.602 using AKIN). There were no differences in clinical outcomes such as mortality, major adverse events, intensive care unit stay or duration of mechanical ventilation. Clotting time as measured using rotational thromboelastometry (ROTEM) was prolonged, and clot firmness after 10 min and maximal clot firmness were shorter in the starch group compared with the control group after sternal closure. There was no difference in transfusion between the two groups. Patients with acute kidney injury had worse clinical courses than those without acute kidney injury. We conclude that intra-operative use of 6% hydroxyethyl starch 130/0.4 up to 30 ml.kg-1 was not associated with postoperative acute kidney injury in paediatric cardiac patients.

来源:Anaesthesia,查看原文。版权归原作者所有。

引用

  1. Oh HW, Lee JH, Kim HC, et al. The effect of 6% hydroxyethyl starch (130/0.4) on acute kidney injury in paediatric cardiac surgery: a prospective, randomised trial. Anaesthesia. 2017. PMID: 29150842. doi:10.1111/anae.14129

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。